ResNovas Therapeutics
PrivateLast Round
Grant
Apr 28, 2026
Total Funding Raised
$500,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ResNovas Therapeutics is a drug discovery company developing targeted protein degradation therapies designed to enable treatment of disease at the molecular level.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ResNovas Therapeutics Comparables
Compare ResNovas Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neuvivo | 80% | |
| QurAlis | 76% | |
| Coya Therapeutics, Inc. | 74% |
ResNovas Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 28, 2026 | ||||
| Pre Seed | Dec 31, 2025 | ||||
| Accelerator | Oct 9, 2025 | ||||
| Accelerator | Sep 30, 2025 | ||||
| Seed | Aug 15, 2024 |
ResNovas Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Pre Seed |
| StartX | Accelerator |
| Dalena Capital | Seed |
| Astellas Venture Management | Seed |
| Ono Venture Investment, Inc. | Pre Seed |
| Mission BioCapital | Pre Seed, Seed |
| TIAP | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 28, 2026
Received grant funding from AbbVie and MBC BioLabs.
- Dec 31, 2025
$500K raised from Ono Venture Investment, Connecticut Innovations, and others.
ResNovas Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ResNovas Therapeutics's valuation, stock price, and market status.
Is ResNovas Therapeutics a public or private company?
ResNovas Therapeutics is a private company.
What is the current stock price of ResNovas Therapeutics?
ResNovas Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is ResNovas Therapeutics worth (valuation)?
Valuation information for ResNovas Therapeutics is not publicly available.
Can I buy ResNovas Therapeutics stock?
ResNovas Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ResNovas Therapeutics's last funding round?
Funding round information for ResNovas Therapeutics is not publicly available.
Who are the main investors in ResNovas Therapeutics?
Investor information for ResNovas Therapeutics is not publicly disclosed.
Will ResNovas Therapeutics IPO soon?
No public IPO plans have been announced for ResNovas Therapeutics.
How can I track ResNovas Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ResNovas Therapeutics's secondary market activity and sign up for updates.